GL Pharma GmbH, Oxylan 40mg prolonged-release tablets
- The problem
- GL Pharma is recalling a specific batch of Oxylan 40mg prolonged-release tablets due to out of specification results for dissolution during routine stability testing.
- What to do
- Check the batch number on your pack against the list below. Do not stop taking a prescribed medicine without talking to your pharmacist, GP or prescriber first – they can check your supply and swap it if needed.
MDR Number
MDR 158-08/20
Company Name
GL Pharma GmbH
Product description
Oxylan 40mg prolonged-release tablets, PL 21597/0064
| Batch Number | Expiry Date | Pack Size | First Distributed |
|---|---|---|---|
| 9F119A | 31/05/2024 | 56 | 02/06/2020 |
Active pharmaceutical ingredient: oxycodone hydrochloride
Advice for healthcare professionals
Stop supplying the above batch immediately. Quarantine all stock and return it to your supplier using your supplier’s approved process.
Further information
For medical information enquiries please contact pv@gl-pharma.at
For stock control enquiries please contact david.hammond@healthcarepharma.co.uk
Recipients of this Drug Alert should bring it to the attention of relevant contacts by copy of this letter.
NHS England and NHS Improvement Regional Offices are asked to forward this alert to community pharmacy contractors.
Download document
Updated 1 September 2020. This page summarises an official notice. Details can change – always follow the official notice.